Orphapacket:
  ORPHApacketId: '803'
  creationDate: '2020-06-27 22:10:58'
  version: 1.3.6 / 4.1.7 [2020-04-17] (orientdb version)
  copyright: Orphanet (c) 2020
  ORPHAcode: '803'
  Label: Amyotrophic lateral sclerosis
  PURL: http://www.orpha.net/ORDO/Orphanet_803
  DisorderType:
    value: Disease
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
  Synonyms:
  - Synonym: ALS
  - Synonym: Charcot disease
  - Synonym: Lou Gehrig disease
  ExternalReferences:
  - ExternalReference:
      Source: OMIM
      Reference: '617892'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '614808'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '615426'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '615515'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '616208'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '616437'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '105400'
      DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
  - ExternalReference:
      Source: OMIM
      Reference: '205250'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '300857'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '606070'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '606640'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '608030'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '608031'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '608627'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '611895'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '612069'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '612577'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '613435'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '613954'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '614696'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  - ExternalReference:
      Source: OMIM
      Reference: '617839'
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
  TextSection:
    TextSectionType: Definition
    Contents: A neurodegenerative disease characterized by progressive muscular paralysis
      reflecting degeneration of motor neurons in the primary motor cortex corticospinal
      tracts brainstem and spinal cord.
  Genes:
  - Gene:
      Symbol: CCNF
      Name: cyclin F
      ExternalReferences:
      - Source: HGNC
        Reference: '1591'
      - Source: OMIM
        Reference: '600227'
  - Gene:
      Symbol: TAF15
      Name: TATA-box binding protein associated factor 15
      ExternalReferences:
      - Source: HGNC
        Reference: '11547'
      - Source: OMIM
        Reference: '601574'
  - Gene:
      Symbol: EPHA4
      Name: EPH receptor A4
      ExternalReferences:
      - Source: HGNC
        Reference: '3388'
      - Source: OMIM
        Reference: '602188'
  - Gene:
      Symbol: ANXA11
      Name: annexin A11
      ExternalReferences:
      - Source: OMIM
        Reference: '602572'
      - Source: HGNC
        Reference: '535'
  - Gene:
      Symbol: CFAP410
      Name: cilia and flagella associated protein 410
      ExternalReferences:
      - Source: HGNC
        Reference: '1260'
      - Source: OMIM
        Reference: '603191'
  - Gene:
      Symbol: GLE1
      Name: GLE1 RNA export mediator
      ExternalReferences:
      - Source: HGNC
        Reference: '4315'
      - Source: OMIM
        Reference: '603371'
  - Gene:
      Symbol: NEK1
      Name: NIMA related kinase 1
      ExternalReferences:
      - Source: HGNC
        Reference: '7744'
      - Source: OMIM
        Reference: '604588'
  - Gene:
      Symbol: GLT8D1
      Name: glycosyltransferase 8 domain containing 1
      ExternalReferences:
      - Source: HGNC
        Reference: '24870'
      - Source: OMIM
        Reference: '618399'
  - Gene:
      Symbol: CHCHD10
      Name: coiled-coil-helix-coiled-coil-helix domain containing 10
      ExternalReferences:
      - Source: HGNC
        Reference: '15559'
      - Source: OMIM
        Reference: '615903'
  - Gene:
      Symbol: DAO
      Name: D-amino acid oxidase
      ExternalReferences:
      - Source: OMIM
        Reference: '124050'
      - Source: HGNC
        Reference: '2671'
  - Gene:
      Symbol: ATXN2
      Name: ataxin 2
      ExternalReferences:
      - Source: HGNC
        Reference: '10555'
      - Source: OMIM
        Reference: '601517'
  - Gene:
      Symbol: CHMP2B
      Name: charged multivesicular body protein 2B
      ExternalReferences:
      - Source: HGNC
        Reference: '24537'
      - Source: OMIM
        Reference: '609512'
  - Gene:
      Symbol: SOD1
      Name: superoxide dismutase 1
      ExternalReferences:
      - Source: HGNC
        Reference: '11179'
      - Source: OMIM
        Reference: '147450'
  - Gene:
      Symbol: TREM2
      Name: triggering receptor expressed on myeloid cells 2
      ExternalReferences:
      - Source: HGNC
        Reference: '17761'
      - Source: OMIM
        Reference: '605086'
  - Gene:
      Symbol: VAPB
      Name: VAMP associated protein B and C
      ExternalReferences:
      - Source: HGNC
        Reference: '12649'
      - Source: OMIM
        Reference: '605704'
  - Gene:
      Symbol: VCP
      Name: valosin containing protein
      ExternalReferences:
      - Source: HGNC
        Reference: '12666'
      - Source: OMIM
        Reference: '601023'
  - Gene:
      Symbol: NEFH
      Name: neurofilament heavy
      ExternalReferences:
      - Source: HGNC
        Reference: '7737'
      - Source: OMIM
        Reference: '162230'
  - Gene:
      Symbol: OPTN
      Name: optineurin
      ExternalReferences:
      - Source: HGNC
        Reference: '17142'
      - Source: OMIM
        Reference: '602432'
  - Gene:
      Symbol: DCTN1
      Name: dynactin subunit 1
      ExternalReferences:
      - Source: HGNC
        Reference: '2711'
      - Source: OMIM
        Reference: '601143'
  - Gene:
      Symbol: TARDBP
      Name: TAR DNA binding protein
      ExternalReferences:
      - Source: HGNC
        Reference: '11571'
      - Source: OMIM
        Reference: '605078'
  - Gene:
      Symbol: FIG4
      Name: FIG4 phosphoinositide 5-phosphatase
      ExternalReferences:
      - Source: HGNC
        Reference: '16873'
      - Source: OMIM
        Reference: '609390'
  - Gene:
      Symbol: FUS
      Name: FUS RNA binding protein
      ExternalReferences:
      - Source: HGNC
        Reference: '4010'
      - Source: OMIM
        Reference: '137070'
  - Gene:
      Symbol: ANG
      Name: angiogenin
      ExternalReferences:
      - Source: HGNC
        Reference: '483'
      - Source: OMIM
        Reference: '105850'
  - Gene:
      Symbol: MATR3
      Name: matrin 3
      ExternalReferences:
      - Source: HGNC
        Reference: '6912'
      - Source: OMIM
        Reference: '164015'
  - Gene:
      Symbol: PRPH
      Name: peripherin
      ExternalReferences:
      - Source: HGNC
        Reference: '9461'
      - Source: OMIM
        Reference: '170710'
  - Gene:
      Symbol: PON1
      Name: paraoxonase 1
      ExternalReferences:
      - Source: HGNC
        Reference: '9204'
      - Source: OMIM
        Reference: '168820'
  - Gene:
      Symbol: PON2
      Name: paraoxonase 2
      ExternalReferences:
      - Source: HGNC
        Reference: '9205'
      - Source: OMIM
        Reference: '602447'
  - Gene:
      Symbol: PON3
      Name: paraoxonase 3
      ExternalReferences:
      - Source: HGNC
        Reference: '9206'
      - Source: OMIM
        Reference: '602720'
  - Gene:
      Symbol: SQSTM1
      Name: sequestosome 1
      ExternalReferences:
      - Source: HGNC
        Reference: '11280'
      - Source: OMIM
        Reference: '601530'
  - Gene:
      Symbol: UBQLN2
      Name: ubiquilin 2
      ExternalReferences:
      - Source: HGNC
        Reference: '12509'
      - Source: OMIM
        Reference: '300264'
  - Gene:
      Symbol: C9ORF72
      Name: C9orf72-SMCR8 complex subunit
      ExternalReferences:
      - Source: HGNC
        Reference: '28337'
      - Source: OMIM
        Reference: '614260'
  - Gene:
      Symbol: PFN1
      Name: profilin 1
      ExternalReferences:
      - Source: HGNC
        Reference: '8881'
      - Source: OMIM
        Reference: '176610'
  - Gene:
      Symbol: TBK1
      Name: TANK binding kinase 1
      ExternalReferences:
      - Source: HGNC
        Reference: '11584'
      - Source: OMIM
        Reference: '604834'
  - Gene:
      Symbol: HNRNPA1
      Name: heterogeneous nuclear ribonucleoprotein A1
      ExternalReferences:
      - Source: HGNC
        Reference: '5031'
      - Source: OMIM
        Reference: '164017'
  - Gene:
      Symbol: PPARGC1A
      Name: PPARG coactivator 1 alpha
      ExternalReferences:
      - Source: HGNC
        Reference: '9237'
      - Source: OMIM
        Reference: '604517'
  - Gene:
      Symbol: ERBB4
      Name: erb-b2 receptor tyrosine kinase 4
      ExternalReferences:
      - Source: HGNC
        Reference: '3432'
      - Source: OMIM
        Reference: '600543'
  - Gene:
      Symbol: UNC13A
      Name: unc-13 homolog A
      ExternalReferences:
      - Source: HGNC
        Reference: '23150'
      - Source: OMIM
        Reference: '609894'
  Parents:
  - Parent:
    - ORPHAcode: '98503'
      Label: Motor neuron disease
  - Parent:
    - ORPHAcode: '182070'
      Label: Rare neurodegenerative disease
  - Parent:
    - ORPHAcode: '183500'
      Label: Genetic neurodegenerative disease
  Phenotypes:
  - Phenotype:
      HPOId: HP:0007354
      HPOTerm: Amyotrophic lateral sclerosis
      HPOFrequency: Obligate (100%)
  - Phenotype:
      HPOId: HP:0002180
      HPOTerm: Neurodegeneration
      HPOFrequency: Very frequent (99-80%)
  - Phenotype:
      HPOId: HP:0003324
      HPOTerm: Generalized muscle weakness
      HPOFrequency: Very frequent (99-80%)
  - Phenotype:
      HPOId: HP:0007373
      HPOTerm: Motor neuron atrophy
      HPOFrequency: Very frequent (99-80%)
  - Phenotype:
      HPOId: HP:0000217
      HPOTerm: Xerostomia
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0000712
      HPOTerm: Emotional lability
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0000716
      HPOTerm: Depressivity
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0000739
      HPOTerm: Anxiety
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0001257
      HPOTerm: Spasticity
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0002094
      HPOTerm: Dyspnea
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0002795
      HPOTerm: Functional respiratory abnormality
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0002878
      HPOTerm: Respiratory failure
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0003202
      HPOTerm: Skeletal muscle atrophy
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0003394
      HPOTerm: Muscle spasm
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0003470
      HPOTerm: Paralysis
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0012378
      HPOTerm: Fatigue
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0012531
      HPOTerm: Pain
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0030192
      HPOTerm: Fatigable weakness of bulbar muscles
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0030195
      HPOTerm: Fatigable weakness of swallowing muscles
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0030196
      HPOTerm: Fatigable weakness of respiratory muscles
      HPOFrequency: Frequent (79-30%)
  - Phenotype:
      HPOId: HP:0000713
      HPOTerm: Agitation
      HPOFrequency: Occasional (29-5%)
  - Phenotype:
      HPOId: HP:0002017
      HPOTerm: Nausea and vomiting
      HPOFrequency: Occasional (29-5%)
  - Phenotype:
      HPOId: HP:0025425
      HPOTerm: Laryngospasm
      HPOFrequency: Occasional (29-5%)
  Prevalences:
  - Prevalence:
      Source: 19710046[PMID]_[EXPERT]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  - Prevalence:
      Source: 19192301[PMID]_[EXPERT]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  - Prevalence:
      Source: 21665992[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Worldwide
  - Prevalence:
      Source: 21665992[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Worldwide
  - Prevalence:
      Source: 17898523[PMID]_17219036[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: United Kingdom
  - Prevalence:
      Source: 17898523[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: United Kingdom
  - Prevalence:
      Source: 10025778[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Ireland
  - Prevalence:
      Source: 10025778[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Ireland
  - Prevalence:
      Source: 6601351[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Finland
  - Prevalence:
      Source: 6601351[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Finland
  - Prevalence:
      Source: 3762972[PMID]_19494548[PMID]_ ORPHANET
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Canada
  - Prevalence:
      Source: 3762972[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Canada
  - Prevalence:
      Source: 25298019[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: United States
  - Prevalence:
      Source: 18334826[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Uruguay
  - Prevalence:
      Source: 18334826[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Uruguay
  - Prevalence:
      Source: 2786160[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Denmark
  - Prevalence:
      Source: 2786160[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Denmark
  - Prevalence:
      Source: 19237701[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Italy
  - Prevalence:
      Source: 19237701[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Italy
  - Prevalence:
      Source: 19452307[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: France
  - Prevalence:
      Source: 23286747[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Spain
  - Prevalence:
      Source: 23286747[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Spain
  - Prevalence:
      Source: 21860251[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Norway
  - Prevalence:
      Source: 21860251[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Norway
  - Prevalence:
      Source: DOI:10.1016/j.jfma.2013.01.008[OTHER]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Taiwan, Province of China
  - Prevalence:
      Source: DOI:10.1016/j.jfma.2013.01.008[OTHER]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Taiwan, Province of China
  - Prevalence:
      Source: 22034926[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Faroe Islands
  - Prevalence:
      Source: 20214678[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Iran, Islamic Republic of
  - Prevalence:
      Source: 20214678[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Iran, Islamic Republic of
  - Prevalence:
      Source: 23052600[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Specific population
  - Prevalence:
      Source: 23052600[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-5 / 10 000
      ValMoy: no data
      PrevalenceGeographic: Specific population
  - Prevalence:
      Source: 22409362[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Specific population
  - Prevalence:
      Source: 22409362[PMID]
      PrevalenceType: Point prevalence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Specific population
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  AverageAgeOfDeaths:
    AverageAgeOfDeath:
    - value: adult
  TypeOfInheritances:
  - TypeOfInheritance:
      value: Autosomal dominant
  - TypeOfInheritance:
      value: Autosomal recessive
  - TypeOfInheritance:
      value: Not applicable
